Virologic Data
| Patient . | Immune Status . | IVIG Total Dose (g) . | HCV-Ab . | HCV-RNA After IVIG . | HCV Genotype . | |
|---|---|---|---|---|---|---|
| . | . | . | Before IVIG . | After IVIG . | . | . |
| AA | ID | 30 | neg* | neg | pos | 1 |
| BF | ID | 28 | neg | neg | pos | 1 |
| FF | ID | 42 | neg | neg | pos | 1 |
| FA | ID | 24 | neg | pos | pos | ND |
| LM | ID | 24 | neg | pos | pos | 1 |
| LF | ID | 31 | neg | neg | pos | 1 |
| VE | ID | 23 | neg* | neg | pos | 1 |
| BI | IC | 28 | neg | pos | pos | 1 |
| BFA | IC | 100 | neg* | pos | ND | ND |
| EG | IC | 125 | neg | pos | neg | |
| GA | IC | 25 | neg | pos | pos | 1 |
| LT | IC | 150 | Unknown | pos | pos | 1 |
| SG | IC | 100 | neg | pos | pos | 1 |
| Patient . | Immune Status . | IVIG Total Dose (g) . | HCV-Ab . | HCV-RNA After IVIG . | HCV Genotype . | |
|---|---|---|---|---|---|---|
| . | . | . | Before IVIG . | After IVIG . | . | . |
| AA | ID | 30 | neg* | neg | pos | 1 |
| BF | ID | 28 | neg | neg | pos | 1 |
| FF | ID | 42 | neg | neg | pos | 1 |
| FA | ID | 24 | neg | pos | pos | ND |
| LM | ID | 24 | neg | pos | pos | 1 |
| LF | ID | 31 | neg | neg | pos | 1 |
| VE | ID | 23 | neg* | neg | pos | 1 |
| BI | IC | 28 | neg | pos | pos | 1 |
| BFA | IC | 100 | neg* | pos | ND | ND |
| EG | IC | 125 | neg | pos | neg | |
| GA | IC | 25 | neg | pos | pos | 1 |
| LT | IC | 150 | Unknown | pos | pos | 1 |
| SG | IC | 100 | neg | pos | pos | 1 |
Abbreviations: ID, immunodeficient; IC, immunocompetent. ND, not done.
HCV-Ab test was performed shortly after IVIG infusion.